Menu

PTC Therapeutics, Inc. PTCT

Full chart Compare
Set alert

Price alert · PTCT

All alert types
65.44 USD -0.23 (-0.35%)

At closeNov 6, 2026, 7:38 PM EST

65.39 -0.05 -0.08%

After hours · Nov 6, 7:38 PM ET

65.18 Day range 66.67
59.24 52-week range 89.55
YTD
-13.85%
1 year
-9.85%

Revenue & Expenses

Revenue → Gross Profit: $1.68BGross Profit → Net Income: $682.64MGross Profit → Selling, General & Admin: $347.14MGross Profit → Research & Development: $455.25MRevenue → Cost of Revenue: $47.01MGross Profit → Other Operating Expenses: $15.12MGross Profit → Interest Expense: $152.23MGross Profit → Other Expenses: $17.29MGross Profit → Income Tax: $13.97MGross Profit$1.68BCost of Revenue$47.01MNet Income$682.64MSelling, General & Admin$347.14MResearch & Development$455.25MOther Operating Expenses$15.12MInterest Expense$152.23MOther Expenses$17.29MIncome Tax$13.97MRevenue$1.73B

Latest period ending Dec 31, 2025 · select a line to chart its full history

PTCT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.73B806.78M937.82M698.80M538.59M
1.68B749.38M872.34M654.12M506.26M
866.13M-307.05M-567.20M-473.31M-374.94M
682.64M-363.30M-626.60M-559.02M-523.90M
7.78-4.73-8.37-7.79-7.43
PTCT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
984.65M779.71M594.00M279.83M189.72M
2.90B1.71B1.90B1.71B1.94B
3.10B2.80B2.71B2.05B1.94B
398.70M389.30M415.03M703.63M535.38M
-205.31M-1.10B-818.55M-347.09M1.44M
PTCT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
711.20M-107.69M-158.42M-356.65M-251.33M
-861.98M44.18M-176.74M290.18M219.18M
331.09M255.87M646.40M167.95M20.88M
-8.79M171.55M-28.44M-32.02M-28.21M
203.02M185.03M314.36M98.71M-19.09M